Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT00301119
Official study title

Lung Cancer Biomarkers and Screening

Study summary

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 8, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?NYU Langone Health

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
NYU Langone Health
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • DISEASE CHARACTERISTICS:
  • Screening Cohort
  • At high- or low-risk for lung cancer
  • Smoking history ≥ 20 pack years\
  • With or without workplace exposure to asbestos
  • NOTE: \
  • Participants with \< 20 pack years of smoking are eligible if 50 years of age or older
  • Rule-Out Lung cancer group
  • Referred for evaluation of suspicious nodules with 1 of the following diagnoses:
  • Lung cancer
  • Nonmalignant nodules (control group) PATIENT CHARACTERISTICS:
  • Not pregnant
  • No prior malignancy except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY:
  • Not specified

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • NYU Cancer Institute at New York University Medical CenterNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 8, 2026. Always confirm current availability with the study team.

View original record ↗